Monday, Nov 14, 1983

Dr. Goeddel Of Genentech Receives Prestigious Eli Lilly Award

South San Francisco, Calif. -- November 14, 1983 --

Dr. David V. Goeddel, 32, staff scientist and director of molecular biology at Genentech, Inc. has been named recipient of the 1984 Eli Lilly Award. This prestigious award is presented by the Division of Biological Chemistry of the American Chemical Society, in recognition of outstanding accomplishments in biochemistry.

"This is a great honor not only to Dr. Goeddel but to Genentech," said Robert A. Swanson, company president and chief executive officer. "It is the first time the award has been presented to an industry scientist. Previous winners have been affiliated with universities or research institutes."

Backed by nearly 200 Genentech scientists, Dr. Goeddel has actively contributed to many areas of research, including human growth hormone, the interferons, tissue-type plasminogen activator and cellular oncogenes, which may hold the key to cancer. He received his Ph.D. in Biochemistry from the University of Colorado and was a post doctoral fellow at Stanford Research Institute prior to joining Genentech in 1978.

The Eli Lilly Award was established in 1934 and is administered by The Division of Biological Chemistry of the American Chemical Society, which overseas the selection process. According to the rules of eligibility, the award recipient is chosen on the basis of "outstanding research in biological chemistry of unusual merit for an individual on the threshold of his/her career." (The recipient must be under age 37.) Special consideration is "given to the independence of thought and the originality shown."

# # #